Currently Viewing:
ACCC Annual Meeting & Cancer Center Business Summit
Dr Allen Lichter: Technology Is Present in Oncology, but the Future Is Brighter
March 21, 2019
Envisioning the Future of Cancer Care
March 21, 2019
Joe Flower on Rethinking the Way We Address Cancer Care Delivery
March 21, 2019
Different Vantage Points, but Similar Goals of High-Value Care, Patient Satisfaction
March 22, 2019
Dr John Halamka Outlines Trends in Digital Health
March 22, 2019
Feyi Olopade Ayodele Highlights How CancerIQ Helps With Genetic Testing
March 22, 2019
Ben Jones Outlines Policies Having the Biggest Impact on Cancer Care Delivery
March 23, 2019
Erich Mounce Discusses How Community Oncology Can Address Inequalities in Cancer Care
March 23, 2019
Digital Health Lessons From Around the World
March 24, 2019
Currently Reading
Dr Ali McBride Discusses the Role of Biosimilars in Oncology
March 25, 2019
Alexandra Quinn on the Importance of Sustaining the Role of Community Health Workers in Cancer Care
April 08, 2019
Erich Mounce Discusses How Technology Needs to Evolve to Help Oncologists Deliver Care
April 08, 2019
Ben Jones Weighs the Implications of Site-Neutral Payments
May 24, 2019
Erich Mounce Emphasizes the Importance of Palliative Care
June 01, 2019
Ben Jones Discusses the Impact of Step Therapy in Medicare Advantage
June 07, 2019
Erich Mounce: How Payment Models Are Changing the Way Oncologists Practice
June 14, 2019
Ben Jones: Oncologists Still Face Challenges When Trying to Extract Data From EHRs
June 19, 2019

Dr Ali McBride Discusses the Role of Biosimilars in Oncology

At the Association of Community Cancer Centers (ACCC)'s 45th Annual Meeting & Cancer Center Business Summit, Ali McBride, PharmD, MS, BCPS, BCOP, clinical coordinator of hematology/oncology in the Department of Pharmacy at The University of Arizona Cancer Center and president of ACCC, discussed the role of biosimilars in oncology and how familiar oncologists and their teams are with them.


At the Association of Community Cancer Centers (ACCC)'s 45th Annual Meeting & Cancer Center Business Summit, Ali McBride, PharmD, MS, BCPS, BCOP, clinical coordinator of hematology/oncology in the Department of Pharmacy at The University of Arizona Cancer Center and president of ACCC, discussed the role of biosimilars in oncology and how familiar oncologists and their teams are with them.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up